In non-small-cell lung cancer, CXCR4 inhibitors can reduce the expression of CD73, CD38, and IL-10 on metastasis-initiating cells, thereby rescuing the cytotoxic activity of T cells and preventing TAM polarization, possibly by causing a decrease in adenosine and IL-10 production. The gene discussed is IL10; the disease is non-small cell lung carcinoma.